Todd Davis
Chief Executive Officer at Ligand Pharmaceuticals
About
CEO of Ligand and board member since 2007, with over 30 years of operational and investment experience across more than $4 billion in healthcare financings. He co-founded HealthCare Royalty Partners and previously led biopharmaceutical growth equity investments at Apax Partners.
Colleagues at Ligand Pharmaceuticals
Andrew Reardon
Chief Legal Officer at Ligand Pharmaceuticals
James Pipkin
Vice President, New Product Development at Ligand Pharmaceuticals
Karen Reeves
Senior Vice President, Investments and Head of Clinical Strategy at Ligand Pharmaceuticals
Keith Marschke
Senior Vice President, Biology and Scientific Affairs at Ligand Pharmaceuticals
Lauren Hay
Vice President, Portfolio Strategy and Investments at Ligand Pharmaceuticals
Lee Brown
Vice President, Investments and Business Development at Ligand Pharmaceuticals
Marjorie Fackovec
Head of People Operations at Ligand Pharmaceuticals
Michael Vigilante
Vice President, Investments and Business Development at Ligand Pharmaceuticals